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Abstract Consensus on clinically valid diagnostic
criteria for sarcopenia requires a systematical assess-
ment of the association of its candidate measures of
muscle mass, muscle strength, and physical perfor-
mance on one side and muscle-related clinical parame-
ters on the other side. In this study, we systematically
assessed associations between serum albumin as a
muscle-related parameter and muscle measures in 172
healthy young (aged 18–30 years) and 271 old partici-
pants (aged 69–81 year) from the European MYOAGE
study. Muscle measures included relative muscle mass,
i.e., total- and appendicular lean mass (ALM) percent-
age, absolute muscle mass, i.e., ALM/height2 and total
lean mass in kilograms, handgrip strength, and walking
speed. Muscle measures were standardized and ana-
lyzed in multivariate linear regression models, stratified
by age. Adjustment models included age, body compo-
sition, C-reactive protein and lifestyle factors. In young
participants, serum albumin was positively associated
with lean mass percentage (p=0.007) and with ALM
percentage (p=0.001). In old participants, serum albu-
min was not associated with any of the muscle
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measures. In conclusion, the association between serum
albumin andmusclemeasures was only found in healthy
young participants and the strongest for measures of
relative muscle mass.
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Introduction
The clinical relevance of sarcopenia is increasingly being
recognized. Loss of muscle mass starts around the age of
30 years and has been reported to exceed losses of over
50% by the age of 80 years (Baumgartner et al. 1998;
Bijlsma et al. 2012). Sarcopenia, low muscle mass is
associated with functional impairment, a lower quality
of life, and mortality (Landi et al. 2012; Vandewoude
et al. 2012). To date, there is no consensus regarding
diagnostic criteria: there is debate on which measures of
muscle mass, strength, and function to include, which
correction factors to apply and which cut-off points to use
to determine sarcopenia in clinical practice. The use of
different diagnostic criteria results in a large variety in
prevalence rates of sarcopenia and differences in treat-
ment implications (Bijlsma et al. 2013a; Janssen et al.
2002; Reijnierse et al. 2015; Van Kan 2009).
The definition of sarcopenia should be based on the
strongest associated diagnostic measures with different
muscle-related outcomes. Therefore, studies examining
the association between diagnostic measures of
sarcopenia and muscle-related outcomes are required.
Serum albumin, a protein synthesized by the liver, declines
with increasing age (Mühlberg and Sieber 2004; Bourdel-
Marchasson et al. 2010) and it serves as a muscle-related
parameter by different mechanisms. Muscle acts as a
storage pool for serum albumin: it is stored extracellularly
in muscles and leaks into the muscle cell immediately
after exercise (McNeil and Khakee 1992; Schiaffino and
Partridge 2008). Several causal mechanisms are postulated
by which serum albumin influences muscle mass, i.e., by
its antioxidant capacities (Oettl and Stauber 2007).
Oxidative damage plays a role in the decline of muscle
mass at older age by regulating both muscle protein
synthesis and degradation (Derbré et al. 2014;
Thompson 2009). Moreover, serum albumin is a nonspe-
cific carrier for numerous hormones, including androgens
which action affects not only muscle mass and function
but also an increase in satellite cell number and
myonuclei in the muscle (Sinha-Hikim et al. 2003).
Studies investigating the association between serum albu-
min and muscle measures are controversial and have
reported inconsistent results, which might be explained
by the use of different muscle measures, study designs,
demographic characteristics, and/or different adjustment
models (Baumgartner et al. 1996; Kwon et al. 2007;
Schalk et al. 2005; Schalk et al. 2004; Snyder et al.
2012; Visser et al. 2005).
In order to create evidence-based consensus on clin-
ically valid measures of sarcopenia, associations be-
tween its candidate measures of muscle mass, strength,
and function on one side and muscle-related clinical
parameters on the other need to be systematically ex-
plored (Bijlsma et al. 2014; Bijlsma et al. 2013b, c, d).
We hypothesized that there is an association between
serum albumin as a muscle-related parameter and dif-
ferent muscle measures. As the muscle-related role of
serum albumin is complex and prone to confounders
such as comorbidity hampering correct interpretation,
we aimed to study the aforementioned relation in a
healthy European cohort of young and older people.
Methods
Study design
Data were derived from the MYOAGE study, a cross-
sectional European multicenter study that included
healthy young (aged 18–30 years) and healthy older
(aged 69–81 years) men and women. Young and old
participants were initially included to study age-related
differences in muscle quality, contractile characteristics,
and neural control (McPhee et al. 2013). Participants
were recruited in the Netherlands (Leiden), Finland
(Jyvaskyla), France (Paris), Estonia (Tartu), and the UK
(Manchester) and were recruited via advertisement in
newspapers, at universities, and at associations of emeriti
to make sure that they were cognitively active (McPhee
et al. 2013). Analyses were performed on 443 participants
who had data available on serum albumin levels.
The MYOAGE study aimed to include healthy par-
ticipants only to minimize the confounding effects of
disease on sarcopenia. In short, exclusion criteria includ-
ed a dependent living status, the inability to walk a
distance of 250 m, morbidity (neurologic disorders,
metabolic diseases, rheumatic diseases, recent malig-
nancy, heart failure, severe obstructive pulmonary
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disease (COPD), coagulation disorders), immobilization
for 1 week during the last 3 months, the use of specific
medication (insulin, immunosuppressive drugs), and
orthopedic surgery during the last 2 years or still causing
pain or functional limitation. Those who participated in
athletic events were also excluded (McPhee et al. 2013).
Local medical ethical committees of the participating
medical centers approved the study. After written in-
formed consent was obtained and participants were
medically screened, measurements were performed at
local study centers according to unified and standard-
ized operation procedures (McPhee et al. 2013).
Participant characteristics
A questionnaire was used to assess lifestyle factors such
as physical activity, smoking habits, alcohol use, and
education level. Education level was defined as high
(university), moderate (high school), and low (primary
school). Physically active was defined as exercising at
least three times per week for at least 30 min. Standing
height and body mass were measured for each partici-
pant. Diseases were categorized into cardiovascular dis-
ease (including cardiovascular events, hypertension, and
arterial surgery), non-insulin-dependent diabetes
mellitus, mild COPD, thyroid disease, and osteoarthritis.
Subsequently, the sum score of diseases was deter-
mined. Cognitive function was measured using the
mini-mental state examination (MMSE) (Folstein et al.
1975), and depressive symptoms were measured using
the geriatric depression scale (GDS) (Yesavage and
Sheikh 1986). For inclusion in the MYOAGE study,
all participants needed to have a MMSE score higher
than 23 points and a GDS score lower than 5 points. The
use of medication was registered, and the sum score of
all oral and inhaled medication was indicative of disease
severity (McPhee et al. 2013).
Serum albumin and inflammation status
Blood samples were collected in the morning, while
participants were in a fasting state, and stored at
−80 °C (McPhee et al. 2013). Serum albumin levels
(g/L) were measured by use of a colorimetric assay
using a bromocresol green assay with a Roche
COBAS Integra 800 automated analyzer (Roche
Diagnostics Corp., Indianapolis, USA). Calibration
was performed using the traceability method, standard-
ized against the CRM 470 reference preparation. Two-
point calibration was performed after reagent lot change
and following quality control procedures. Limit of de-
tection of serum albumin was 10 to 70 g/L, lower
detection limit of measurement was 2 g/L. Inter- and
intra-assay coefficients of variation (CV) were 0.4 and
1.7 %, respectively. C-reactive protein (CRP) was used
as a marker of inflammation and measured using an
immunoturbidimetric assay (Roche COBAS Integra
800 automated analyzer, Indianapolis, USA).
Muscle measures
Muscle mass
Muscle mass was determined by dual-energy X-ray
absorptiometry (DXA) (Netherlands, Hologic QDR
4500, version 12.4, Hologic, Inc., Bedford, USA;
Estonia, Lunar Prodigy Advanced, version EnCore
10.51.006 (GE Healthcare, UK); Finland, Lunar
Prodigy, version EnCore 9.30; France, Lunar Prodigy,
version EnCore 12.30; UK, Lunar Prodigy Advance,
version EnCore 10.50.086). Due to these differences in
equipment, data was normalized using country-specific
z scores. Measurements were performed while partici-
pants were in a fasted state, having not eaten anything
for 12 h but having had a glass of water before attending
the laboratory. Alcohol intake and sauna use were not
allowed for at least 24 h, and heavy or strenuous exer-
cise was avoided for 48 h prior to the visit. Scans were
performed while participants were lying in a supine
position, with the arms and legs fully extended.
Standard regions were drawn and manually adapted
only when necessary (McPhee et al. 2013).
Measures of relative muscle mass were calculated as
lean mass divided by body mass (Janssen et al. 2002)
and appendicular lean mass (ALM) as the sum of lean
mass of both arms and legs divided by body mass
(Estrada et al. 2007). These measures were expressed
in percentages. Measures of absolute muscle mass
encompassed adjusted absolute muscle mass by ALM
divided by height squared (ALM/height2) (Baumgartner
et al. 1998) and total lean mass in kilograms.
Muscle strength
Handgrip strength was used to estimate muscle strength
and measured with the Jamar Handgrip Dynamometer
(Sammons Preston, Inc., Bolingbrook, IL, USA), after
adjusting the width of the dynamometer to the size of the
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individual hand. Participants were instructed to stand
upright with the handheld dynamometer, stretching the
arm parallel to, but not pressed against the body. Three
measurements were performed for both hands separate-
ly at a maximal performance, and the highest score was
used for the analyses. Smoking was not allowed in the
2 h prior to muscle function measurements (McPhee
et al. 2013).
Physical performance
Physical performance was measured by the 6-min walking
test wherein participants were instructed to walk around
cones. The cones were placed 20 m apart, with exception
of France where the cones were placed 25 m apart.
Participants were instructed to walk as fast as possible in
Finland, Estonia, the United Kingdom (UK) and France,
while theywere instructed towalk at their usual pace in the
Netherlands (McPhee et al. 2013). Walking speed was
determined from the measured distance over a total of
6 min and expressed in meters per second (m/s).
Statistical analyses
Statistical analyses were performed separately for young
and old participants. Descriptive analyses were per-
formed to determine participant characteristics.
Variables with a Gaussian distribution are presented as
mean and standard deviation (SD), while those with a
non-Gaussian distribution are presented as median and
interquartile range (IQR). Muscle measures were stan-
dardized by country and gender specific z scores to
minimize the effects due to the use of different equip-
ment and to allow comparison of effect sizes of serum
albumin and their association with muscle measures.
Multivariate linear regression analyses were performed
to assess the association between serum albumin and
muscle measures, while taking different adjustment
models stratified by age into account. In model 1, analyses
were adjusted for age to exclude residual confounding by
age. In model 2, analyses were further adjusted for body
mass, fat mass, or height. Lean mass and ALM percent-
ages were adjusted for body mass because a higher body
mass is associated with a lower relative muscle mass
(Delmonico et al. 2007; Lebrun et al. 2006). Total lean
mass in kilograms and ALM/height2 were adjusted for fat
mass because these twomeasures do not take fat mass into
account. Handgrip strength was adjusted for body mass
and height because taller people and people with a higher
body mass may have a higher handgrip strength (Bassey
and Harries 1993; Ramlagan et al. 2014). Walking speed
was adjusted for height because taller people may have a
higher walking speed (Bendall et al. 1989; Troosters et al.
1999). In model 3, analyses were further adjusted for CRP
as a marker of inflammation and lifestyle factors including
physically active, current alcohol use, and current
smoking.
Results of the regression analyses can be interpreted
as follows: a 1-g/L higher serum albumin level is asso-
ciated with a β×SD score of the muscle measure. The
Statistical Package for the Social Sciences (SPSS) ver-
sion 17.0was used for the analyses (SPSS Inc., Chicago,
IL, USA), and p values of <0.05 were considered statis-
tically significant.
Results
A total of 172 young (mean age 23.4 years, SD 2.8) and
271 old (mean age 74.5 years, SD 3.3) participants were
included. Table 1 shows the participant characteristics,
stratified by age. Young and old participants had low
numbers of comorbidities and medication use. No sig-
nificant differences in gender and CRP levels <3 mg/L
distribution were found between young and old partic-
ipants. Mean serum albumin levels were 48.4 g/L (SD
3.1) in young participants and 44.8 g/L (SD 2.8) in old
participants.
Table 2 shows the association between serum albu-
min and standardized muscle measures. In young par-
ticipants, serum albumin was positively associated with
leanmass percentage after adjusting for bodymass. This
association did not change after further adjustment for
CRP and lifestyle factors. Serum albumin was positively
associated with ALM percentage after adjustment for
age. This association strengthened after further adjust-
ment for body mass, CRP, and lifestyle factors. Further
adjustment for CRP and lifestyle factors did not change
the results. Serum albumin was not associated with
ALM/height2, handgrip strength, and walking speed in
all three models. In old participants, serum albumin was
not associated with any of the muscle measures.
Discussion
The aim of the present study was to investigate the
association between serum albumin and different
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muscle measures. In young participants, serum albumin
was positively associated with both measures of relative
muscle mass after adjustments for age, body mass, CRP,
and lifestyle factors. Serum albumin was not associated
with both measures of absolute muscle mass, handgrip
strength, and walking speed in young participants. In
old participants, serum albumin was not associated with
any of the muscle measures.
In the present study, serum albumin was not associ-
ated with measures of absolute muscle mass and hand-
grip strength in young and old participants. Results from
previous studies are controversial. In old participants, a
positive association was found between serum albumin
and relative and absolute muscle mass (Baumgartner
et al. 1996; Visser et al. 2005). In accordance with our
findings, a cross-sectional and a longitudinal study also
failed to find an association between serum albumin and
muscle strength in community-dwelling older partici-
pants (Kwon et al. 2007; Snyder et al. 2012).
However, a longitudinal study has found a negative
association between low baseline serum albumin and a
decline in handgrip strength in community-dwelling old
participants (Schalk et al. 2005). Aforementioned stud-
ies included large heterogeneous populations with vari-
ous physical activity levels and health status in contrast
to our healthy population. In the present study, we did
not find an association between serum albumin and
walking speed. In line with this result, previous studies
also failed to find an association between serum albumin
and walking speed (Schalk et al. 2004; Singh et al.
2014).
The present population of healthy old participants
was the result of a rigorous selection. Only healthy and
fit older persons were included, thus eliminating the
effects of morbidity as much as possible and preventing
other factors than muscle aging alone to interfere with
the association between serum albumin and muscle
measures. The result of this selection may be reflected
by the low standard deviations of both serum albumin
and muscle measures in the old participants, which were
even lower than in the young participants. It could be
that the resulting limited contrast contributed to the
absence of associations between serum albumin and
muscle measures in older group. However, in contrast
to our results, previous studies did report an association
between serum albumin and relative and absolute mus-
cle mass in old participants, while the studies also re-
ported low standard deviations of serum albumin levels
(Baumgartner et al. 1996; Visser et al. 2005). A negative
association was found between a lower baseline serum
albumin (mean 40.0 g/L, 3.1 SD) and a decline in ALM
percentage in community-dwelling people aged 70 years
and older (Visser et al. 2005). Therefore, results of the
former studies might be driven by other factors than
muscle aging itself. Literature does not support our
expectations that in relevant geriatric populations, such
as community-dwelling older adults (mean 43.1 g/L, 2.7





Age, years 23.4 (2.8) 74.5 (3.3)
Male, n (%) 82 (47.7) 131 (48.3)
Highly educated, n (%)a 131 (76.2) 94 (34.7)
Lifestyle factors
Current alcohol use, n (%) 141 (82.0) 191 (70.7)
Current smoking, n (%) 24 (14.0) 13 (4.8)
Physically active, n (%)b 93 (66.4) 120 (52.4)
Comorbidity
Nr. of diseases, median [IQR] 0 [0–0] 1 [0–1]
Nr. of medications, median [IQR] 0 [0–1] 1 [0–3]
Mental state
MMSE score (points), median [IQR] 30 [29–30] 29 [28–30]
GDS score (points), median [IQR] 0 [0–1] 1 [0–2]
Blood parameters
Serum albumin (g/L) 48.4 (3.1) 44.8 (2.8)
CRP <3 (mg/L), n (%) 150 (87.2) 232 (85.6)
Anthropometry
Height (m) 1.73 (0.09) 1.67 (0.09)
Body mass (kg) 68.6 (12.1) 71.4 (12.7)
Fat mass (kg) 16.0 (6.8) 21.5 (7.4)
Muscle measures
Lean mass percentage (%)c 73.2 (9.0) 67.3 (8.3)
ALM percentage (%)d 33.2 (4.7) 28.8 (4.1)
ALM/height2 (kg/m2) 7.5 (1.3) 7.2 (1.1)
Total lean mass (kg) 50.2 (11.4) 47.8 (9.9)
Handgrip strength (kg) 42.3 (12.3) 32.9 (9.4)
Walking speed (m/s) 1.85 (0.3) 1.46 (0.2)
Variables are presented as mean (SD) unless indicated otherwise
IQR interquartile range, SD standard deviation, MMSE mini-
mental state examination, GDS geriatric depression scale, CRP
C-reactive protein, ALM appendicular lean mass
a University level
b Exercising at least three times per week for 30 min
c Total lean mass as percentage of total body mass
dALM as percentage of total body mass
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SD) (Takata et al. 2012) and nursing home residents
(mean 40.1 g/L, 4.4 SD) (Onem et al. 2010); the varia-
tion in serum albumin is higher thereby inducing asso-
ciations with muscle measures. However, these studies
did not address the association between serum albumin
and muscle measures.
There are several mechanisms, which may interfere
with the association between serum albumin and muscle
measures which can be hypothesized to exist in both
directions. A positive association of relative muscle
mass in young participants indicates the importance of
body composition in the relation between serum albu-
min and muscle. In old participants, both serum albumin
and muscle measures were lower compared to young
participants. Direction of causality could change with
advanced age. For example, change of body composi-
tion may turn a dominant role of the reservoir function
of muscle tissue for albumin in younger subjects into a
less prominent role in older subjects in which relative
muscle mass is lower. This is in concordance with the
association of relative muscle mass in younger subjects.
Mechanisms in the opposite direction can also be
Table 2 Association between serum albumin and standardized muscle measures, stratified by age (n=443)
Young (n=172) Old (n=271)
β SE p value β SE p value
Z Lean mass percentage (%)
Model 1: age 0.04 0.02 0.06 −0.01 0.02 0.76
Model 2: as 1+ body mass 0.06 0.02 0.008 −0.01 0.02 0.64
Model 3: as 2+ CRP+lifestyle 0.07 0.02 0.007 −0.01 0.02 0.53
Z ALM percentage (%)
Model 1: age 0.05 0.02 0.017 0.00 0.02 0.89
Model 2: as 1+ body mass 0.06 0.02 0.002 0.00 0.02 0.92
Model 3: as 2+ CRP+ lifestyle 0.07 0.02 0.001 0.00 0.02 0.80
Z ALM/height2 (kg/m2)
Model 1: age −0.01 0.03 0.86 0.02 0.02 0.43
Model 2: as 1+ fat mass 0.02 0.03 0.53 0.01 0.02 0.57
Model 3: as 2+ CRP+ lifestyle 0.03 0.03 0.34 0.01 0.02 0.52
Z Total lean mass (kg)
Model 1: age 0.00 0.03 0.94 0.01 0.02 0.77
Model 2: as 1+ fat mass 0.02 0.03 0.44 0.00 0.02 0.95
Model 3: as 2+ CRP+ lifestyle 0.05 0.03 0.13 −0.01 0.02 0.57
Z Handgrip strength (kg)
Model 1: age 0.01 0.02 0.68 0.00 0.02 0.98
Model 2: as 1+ body mass+height 0.03 0.02 0.26 0.00 0.02 0.83
Model 3: as 2+ CRP+ lifestyle 0.02 0.03 0.36 0.00 0.02 0.83
Z Walking speed (m/s)
Model 1: age 0.01 0.02 0.77 −0.02 0.02 0.29
Model 2: as 1+ height 0.00 0.02 0.85 −0.02 0.02 0.39
Model 3: as 2+ CRP+ lifestyle 0.02 0.02 0.42 0.00 0.02 0.97
All muscle measures were standardized into country and gender specific z scores. All p values were assessed with linear regression analysis
and adjusted in separate models. Lifestyle factors included physically active, current alcohol use, and current smoking. Bold entries are
significant values of p<0.05. Interpretation: a 1-g/L higher serum albumin level is associated with aβ×SD score of themuscle measure; e.g.,
a 1-g/L higher serum albumin level is associated with 0.36 (0.04 bèta z score×9.0 SD) higher lean mass percentage. SD scores of muscle
measures: lean mass percentage: young 9.0%, old 8.3%; ALM percentage: young 4.7%, old 4.1%; ALM/height2 : young 1.3 kg/m2 , old
1.1 kg/m2 ; total lean mass: young 11.4 kg, old 9.9 kg; handgrip strength: young 12.3 kg, old 9.4 kg; walking speed: young 0.3 m/s, old
0.2 m/s
β bèta, SE standard error, CRP C-reactive protein, ALM appendicular lean mass
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hypothesized. Low serum albumin could lead to more
antioxidant capacities (Oettl and Stauber 2007), causing
more oxidative damage and therefore more muscle
breakdown (Derbré et al. 2014; Thompson 2009).
Another mechanism could be the activation of the
phosphatidyl-inositol 3-kinase pathway by serum albu-
min (Jones et al. 2003), leading to muscle hypertrophy
(Lai et al. 2004) and therefore an increase in muscle
mass. Serum albumin may affect serum testosterone
(Vermeulen et al. 1996) and low free testosterone was
found to be associated with low absolute muscle mass,
expressed as ALM/height2 (Yuki et al. 2013). However,
total testosterone was not associated with low absolute
muscle mass in an earlier study (Yuki et al. 2013). Due
to the cross-sectional design of the study, causal rela-
tions cannot be inferred. Therefore, we refrained from
extensive exploration of this topic. As we cannot dem-
onstrate these causal mechanisms due to the cross-
sectional design, we assume the change in body com-
position could explain the differences between the
young and old participants.
Several strengths and limitations of the present study
should be addressed. Since the MYOAGE study
consisted of healthy participants, the influence of dis-
eases on muscle measures was minimized. Furthermore,
previous studies only investigated the association be-
tween serum albumin and muscle strength (Kwon et al.
2007; Schalk et al. 2005; Snyder et al. 2012) or muscle
mass (Baumgartner et al. 1996; Visser et al. 2005). The
present study examined these associations simulta-
neously and additionally included physical perfor-
mance. In addition, we adjusted for CRP as proxy for
inflammation, which is in contrast to other studies
(Kwon et al. 2007; Schalk et al. 2004; Snyder et al.
2012; Starling et al. 1999). It is important to take in-
flammation into account because it is associated both
with a decline in muscle strength (Schaap et al. 2009)
and muscle mass (Malafarina et al. 2012). Our study
was limited by the use of a cross-sectional study design
whereby causality cannot be proven. The cohort
consisted of a relatively small but very defined sample
size. Serum albumin was measured by use of a colori-
metric assay instead of nephelometry as the golden
standard. However, colorimetric assays are often used
in daily clinical practice (Infusino and Panteghini 2013).
In conclusion, serum albumin as a muscle-related
parameter was positively associated with both measures
of relative muscle mass in healthy young participants,
while serum albumin was not associated with any of the
muscle measures in healthy old participants. Future
studies should systematically investigate the association
of other muscle-related clinical parameters with muscle
measures to create evidence-based consensus of
sarcopenia.
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